BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3400353)

  • 1. [Iron balance in hemodialysis in chronic uremia].
    Kokot F; Warmuz A
    Z Urol Nephrol; 1988 Apr; 81(4):263-8. PubMed ID: 3400353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum ferritin concentration: a reliable guide to iron overload in uremic and hemodialyzed patients.
    Aljama P; Ward MK; Pierides AM; Eastham EJ; Ellis HA; Feest TG; Conceicao S; Kerr DN
    Clin Nephrol; 1978 Sep; 10(3):101-4. PubMed ID: 699405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron absorption measured by whole body counting and the relation to marrow iron stores in chronic uremia.
    Milman N
    Clin Nephrol; 1982 Feb; 17(2):77-81. PubMed ID: 6802544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited value of zinc protoporphyrin as a marker of iron status in chronic hemodialysis patients.
    Canavese C; Grill A; Decostanzi E; Maddalena E; Barbieri S; Martina G; Fop F; Buglione E; Grechi D; David O; Saitta M; Piccoli G
    Clin Nephrol; 2000 Jan; 53(1):42-7. PubMed ID: 10661481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A; Karkar A; Abdelrahman M
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum ferritin in renal insufficiency, hemodialysis and kidney transplantation].
    Hofmann V; Descoeudres C; Montandon A; Galeazzi RL; Straub PW
    Schweiz Med Wochenschr; 1978 Nov; 108(47):1835-8. PubMed ID: 362527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minor impairment of oral iron absorption in non-diabetic new dialysis patients.
    Tovbin D; Schnaider A; Vorobiov M; Rogachev B; Basok A; Shull P; Novack V; Friger M; Avramov D; Zlotnik M
    J Nephrol; 2005; 18(2):174-80. PubMed ID: 15931645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma transferrin and the relation to iron status in patients with chronic uremia.
    Milman N
    Clin Nephrol; 1981 Dec; 16(6):314-20. PubMed ID: 6172227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum ferritin and iron therapy in patients treated with periodic hemodialysis].
    Docci D; Cenciotti L; Turci F; Salvi G; Mosconi G; Baldrati L
    Quad Sclavo Diagn; 1982 Dec; 18(4):454-62. PubMed ID: 7186648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study of anemia in 86 patients on hemodialysis (author's transl)].
    Serra A; Camps J; Morlans M; Olmos A; Carrera A; Soriano B; Rodríguez JA; Pelegrí A; Bartolomé J; Piera L
    Med Clin (Barc); 1981 May; 76(10):439-43. PubMed ID: 7242164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum ferritin in children with disorders of iron balance].
    Müller-Wiefel DE; Brendlein F; Ehrlich J; Brandeis WE; Schärer K
    Helv Paediatr Acta; 1982 Jun; 37(3):245-56. PubMed ID: 7118557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low serum aluminum values in dialysis patients with increased bone aluminum levels.
    van Landeghem GF; D'Haese PC; Lamberts LV; Djukanovic L; Pejanovic S; Goodman WG; De Broe ME
    Clin Nephrol; 1998 Aug; 50(2):69-76. PubMed ID: 9725776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients.
    Kalantar-Zadeh K; Don BR; Rodriguez RA; Humphreys MH
    Am J Kidney Dis; 2001 Mar; 37(3):564-72. PubMed ID: 11228181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of continuous ambulatory peritoneal dialysis on anemia in uremic patients.
    Marcovici O; Boner G; Rosenfeld JB
    Isr J Med Sci; 1983 Jul; 19(7):604-7. PubMed ID: 6885343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between serum parathyroid hormone and trace elements (serum zinc and magnesium) in hemodialyzed chronic renal failure children.
    El Tayeb AA; Abd El-Mottaleb NA; Abdel Aziz EA
    Biol Trace Elem Res; 2009 May; 128(2):128-34. PubMed ID: 18972069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
    Chudek J; Piecha G; Kokot F; Wiecek A
    J Nephrol; 2003; 16(5):710-5. PubMed ID: 14733418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC; Hung SC; Tarng DC
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum prohepcidin and hepcidin in hemodialyzed patients undergoing iron therapy.
    Malyszko J; Malyszko JS; Mysliwiec M
    Kidney Blood Press Res; 2009; 32(4):235-8. PubMed ID: 19713706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.